Page last updated: 2024-10-29

indirubin-3'-monoxime and Acute Confusional Senile Dementia

indirubin-3'-monoxime has been researched along with Acute Confusional Senile Dementia in 3 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Research Excerpts

ExcerptRelevanceReference
"Indirubins were recently described as potent (IC(50): 50-100 nm) inhibitors of cyclin-dependent kinases (CDKs)."1.31Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? ( Bibb, JA; Biernat, J; Eisenbrand, G; Garnier, M; Greengard, P; Hoessel, R; Leclerc, S; Mandelkow, EM; Marko, D; Meijer, L; Snyder, GL; Wu, YZ, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Leclerc, S1
Garnier, M1
Hoessel, R1
Marko, D1
Bibb, JA1
Snyder, GL1
Greengard, P1
Biernat, J1
Wu, YZ1
Mandelkow, EM1
Eisenbrand, G1
Meijer, L1
Choudhary, BS1
Mehta, P1
Bach, S1
Ruchaud, S1
Robert, T1
Josselin, B1
Filipek, S1
Malik, R1
Ding, Y1
Qiao, A1
Fan, GH1

Other Studies

3 other studies available for indirubin-3'-monoxime and Acute Confusional Senile Dementia

ArticleYear
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    The Journal of biological chemistry, 2001, Jan-05, Volume: 276, Issue:1

    Topics: Adenosine Triphosphate; Alkaloids; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Calcium-

2001
Discovery of thiazolidin-4-one analogue as selective GSK-3β inhibitor through structure based virtual screening.
    Bioorganic & medicinal chemistry letters, 2021, 11-15, Volume: 52

    Topics: Alzheimer Disease; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; G

2021
Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease.
    Neurobiology of disease, 2010, Volume: 39, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Anim

2010